NDC codes

415464 NDC codes with hospital pricing data in the network.

• NDC 60687-0453-01 — LEVOTHYROXINE 25 MCG TABLETAI (535 hospitals, 29,904–30,912 samples)
• NDC 51079-0684-20 — Atenolol 50 mg tabletsAI (746 hospitals, 30,025–30,907 samples)
• NDC 00078-0502-61 — Rivastigmine 9.5 mg/24-hour skin patchAI (187 hospitals, 30,120–30,903 samples)
• NDC 00065-0647-05 — Tobramycin and dexamethasone eye dropsAI (117 hospitals, 29,957–30,902 samples)
• NDC 63323-0808-11 — Fentanyl citrate injection, preservative-free prefilled syringeAI (319 hospitals, 28,063–30,898 samples)
• NDC 51672-4048-06 — Clotrimazole-betamethasone topical creamAI (145 hospitals, 29,966–30,893 samples)
• NDC 00023-9637-04 — Oxybutynin 3.9 mg/24 hour skin patch, 4-day supplyAI (57 hospitals, 29,966–30,893 samples)
• NDC 00713-0849-09 — Hydrocortisone and acetic acid ear dropsAI (38 hospitals, 29,966–30,893 samples)
• NDC 00517-4605-25 — Glycopyrrolate injection, 0.2 mg/mLAI (294 hospitals, 28,894–30,892 samples)
• NDC 00143-9331-10 — Bupivacaine local anesthetic injectionAI (338 hospitals, 28,915–30,886 samples)
• NDC 00338-9541-24 — Metronidazole 500 mg IV solutionAI (317 hospitals, 29,730–30,882 samples)
• NDC 17478-0223-12 — PILOCARPINE 1 % EYE DROPSAI (208 hospitals, 29,963–30,863 samples)
• NDC 00121-1012-95 — LACOSAMIDE 10 MG/ML ORAL SOLUTIONAI (87 hospitals, 29,920–30,856 samples)
• NDC 60687-0242-01 — Sertraline 50 mg tabletsAI (742 hospitals, 29,660–30,848 samples)
• NDC 17478-0716-10 — APRACLONIDINE 0.5 % EYE DROPSAI (155 hospitals, 29,961–30,843 samples)
• NDC 63323-0202-02 — Lidocaine 2% injection solutionAI (527 hospitals, 27,727–30,832 samples)
• NDC 00378-9124-16 — Fentanyl 100 mcg/hr transdermal patchAI (366 hospitals, 30,031–30,832 samples)
• NDC 17478-0215-02 — Atropine 1% eye drops, 2 mL bottleAI (361 hospitals, 29,837–30,800 samples)
• NDC 63323-0208-01 — Lidocaine heart-rhythm injection, 100 mg per 5 mLAI (237 hospitals, 27,811–30,799 samples)
• NDC 68084-0318-01 — Lamotrigine 25 mg oral tabletsAI (552 hospitals, 29,929–30,793 samples)
• NDC 50383-0025-05 — OFLOXACIN 0.3 % EAR DROPSAI (141 hospitals, 29,956–30,793 samples)
• NDC 54838-0523-40 — Fluoxetine liquid 20 mg per 5 mL, 120 mL bottleAI (361 hospitals, 29,835–30,780 samples)
• NDC 00378-9122-16 — Fentanyl 50 mcg/hr transdermal patchAI (383 hospitals, 29,780–30,779 samples)
• NDC 00378-0872-16 — Clonidine 0.2 mg weekly transdermal patchAI (410 hospitals, 29,896–30,778 samples)
• NDC 00264-4500-00 — Plenamine 15% IV amino acid solutionAI (242 hospitals, 30,614–30,776 samples)
• NDC 70092-1135-44 — Topical lidocaine, epinephrine and tetracaine gelAI (249 hospitals, 29,820–30,774 samples)
• NDC 68084-0214-11 — Benzonatate 100 mg capsulesAI (576 hospitals, 30,142–30,772 samples)
• NDC 60505-6226-00 — Atropine sulfate 1% eye dropsAI (396 hospitals, 29,853–30,771 samples)
• NDC 51079-0205-20 — Allopurinol 100 mg tablets, blister pack of 100AI (643 hospitals, 30,011–30,767 samples)
• NDC 47335-0788-91 — Desmopressin nasal sprayAI (400 hospitals, 29,852–30,761 samples)
• NDC 00069-0238-01 — Ruxience (rituximab-pvvr) 100 mg IV infusion vialAI (956 hospitals, 30,146–30,758 samples)
• NDC 00487-9003-60 — Hypertonic saline 3% nebulizer solutionAI (251 hospitals, 30,383–30,743 samples)
• NDC 60687-0394-79 — Ipratropium bromide 0.02% inhalation solutionAI (468 hospitals, 29,730–30,738 samples)
• NDC 71839-0120-01 — Sodium nitroprusside injection solutionAI (77 hospitals, 29,616–30,732 samples)
• NDC 70004-0841-40 — Potassium phosphate IV solution in salineAI (72 hospitals, 29,941–30,724 samples)
• NDC 73702-0301-15 — Ketamine 50 mg/5 mL intravenous syringeAI (96 hospitals, 29,814–30,714 samples)
• NDC 00904-5959-61 — Clindamycin 150 mg capsulesAI (815 hospitals, 29,880–30,708 samples)
• NDC 00264-7806-10 — Hypertonic saline 5% IV solutionAI (48 hospitals, 30,662–30,707 samples)
• NDC 00904-6828-94 — Oxycodone 5 mg/5 mL oral liquidAI (225 hospitals, 29,914–30,706 samples)
• NDC 00904-7224-61 — Folic acid 1 mg tabletsAI (528 hospitals, 29,919–30,702 samples)
• NDC 50383-0889-15 — Acetic acid 2% ear dropsAI (170 hospitals, 29,827–30,700 samples)
• NDC 50419-0325-03 — Gadobutrol contrast agent injectionAI (141 hospitals, 27,620–30,698 samples)
• NDC 17478-0030-05 — Fentanyl injection, 50 mcg per mLAI (219 hospitals, 28,732–30,694 samples)
• NDC 63739-0544-10 — Spironolactone 25 mg tabletsAI (689 hospitals, 29,984–30,686 samples)
• NDC 70092-9114-50 — Hydromorphone pain medicine in IV pump syringeAI (87 hospitals, 29,735–30,671 samples)
• NDC 00409-4699-30 — propofol 10 mg/mL intravenous emulsionAI (250 hospitals, 29,202–30,660 samples)
• NDC 00904-6860-61 — Divalproex sodium 250 mg delayed-release tabletAI (593 hospitals, 29,800–30,655 samples)
• NDC 60687-0544-01 — CLONAZEPAM 0.5 MG TABLETAI (351 hospitals, 29,980–30,646 samples)
• NDC 70860-0301-42 — Diltiazem injection, 5 mg/mLAI (223 hospitals, 29,437–30,634 samples)
• NDC 00378-8270-93 — Albuterol sulfate 2.5 mg nebulizer solutionAI (240 hospitals, 28,392–30,633 samples)